Tensins are structural adaptor proteins localized at focal adhesions. Tensins can act as 20 mechanosensors and participate in the transduction of biochemical signals from the extracellular -(A) Structure of members of the Tensin family. contain an ABD (actin 117 binding domain), SH2 (Src homology 2) domain and PTB (phosphotyrosine binding domain). Tensin-2 has a 118 conserved protein kinase C region 1 that is not present in other Tensins. TNS4 has a SH2 domain and PTB domain 119 but lacks the ABD. Among all Tensins, Nuclear localization signal (NLS) and Nuclear export signal (NES) was 120 identified in TNS4. (B) Molecular Phylogenetic analysis of tensins by Maximum Likelihood method. 121 122 PeerJ Preprints | https://doi.org/10.7287/peerj.preprints.27990v1 | CC BY 4.0 Open Access | rec
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The subcellular localization of a protein is important for its biological function (Butler & 166 Overall, 2009). Like other tensin members, TNS4 mainly localizes to focal adhesion complex 167 (Lo, 2014) , where it recruits and stabilizes several proteins and enhances cellular functions 168 (Table 1) (Hong et al., 2019b) . 174 We ourselves have also searched for an NLS and we have discovered a putative NLS protein 175 motif common to tensins 1, 3 and 4 (KLFFRRHYP), but absent in TNS2 (Figure 3 ). The score of 176 the NLS region in TNS2 representing its likelihood to translocate into the nucleus was also lower 177 (5.4) than for the other tensins (between 6-8) with the highest scoring NLS being that of tensin4, 178 indicating it is the most likely protein to have nuclear translocation. Even though nuclear 179 translocation of TNS1 and 3 and its effects has not been reported yet, it is very probable these 180 tensins, as in the case of TNS4, signal to the nucleus and shuttle between the nucleus and the 181 cytoplasm. 
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Although the tensins are mainly structural proteins without any enzymatic domains, they play a 188 significant role in cell signalling as part of their role in regulating cell adhesion and cellular 189 interaction with the extracellular matrix. Interactions between the four different tensins and 190 epidermal growth factor receptor signalling have been reported. The most explored of these is 191 TNS4 and recently it has been shown that TNS4 is involved in the transduction of extra-celluar 192 signals for a wide variety of growth factors. These data place TNS4 at the heart of a nexus of 193 signalling pathways, the paradigm of which would be EGFR/KRAS/MAPK signalling (Albasri 194 et al., 2011a; Al-Ghamdi et al., 2013; Thorpe et al., 2015; Asiri et al., 2018b Asiri et al., , 2019 . In this 195 pathway, TNS4 has been shown to mediate its effect through the reduction of EGFR degradation 196 (Hong et al., 2013) by interacting with the phosphotyrosine residues of EGFR through its SH2 197 domain ( Figure 4 ). This ability to bind to phosphotyrosines in EGFR is also present in both of 198 the SH2 and PTB domains of TNS2, but not those of TNS1 and 3. However, Tensins 1 -3 are 199 able to interact with phosphotyrosine residues of ErbB2, whereas TNS4 is not (Jones et al., 200 2006) . The complexity of the relationships between the tensins is shown in untransformed breast 201 cells where activation of ErbB2 (a member of the EGFR family) results in a displacement of 202 TNS3 by TNS4 at focal adhesions (called the "tensin switch") (Katz et al., 2007) . The 203 mechanistic basis of this switch is not known but, in colorectal cancer, this switch is not seen and 204 our data shows that in fact levels of both TNS3 and TNS4 increase following EGF stimulation 205 (Thorpe et al., 2015) ( Figure 5 ).
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Organ
In vitro assays of TNS4 function TNS4 expression in Clinical samples
Normal Prostate
Cleaved during apoptosis (Lo, Lo & Lo, 2005) . Increases cell adhesion (Yang et al., 2016b) . Disturbs acinar formation (Wu & Liao, 2018) .
TNS4 expression was higher in three out of four cases when compared to tumour adjacent tissue (Lo & Lo, 2002b) .
Normal human skin
Induces proliferation and possibly differentiation (Seo et al., 2017a) . Localized in basal layer keratinocytes. Downregulated in differentiated keratinocytes (Seo et al., 2017a) .
Normal mammary gland, Breast
Induces cell migration (Katz et al., 2007) . TNS4 expression not detected (Albasri et al., 2011a) .
Prostate cancer
No data reported.
Downregulated in three out of four cases when compared to normal adjacent tissue (Lo & Lo, 2002b) . TNS4 protein expression correlated inversely with Gleason score (Li et al., 2010b) .
Melanoma
No data reported. TNS4 expression correlated positively with tumour thickness and associated with poorer prognosis and response to treatment (Sjoestroem et al., 2013b) .
Breast cancer
Overexpression of TNS4 (571-715) induces apoptosis whereas overexpression of full length TNS4 did not (Lo, Lo & Lo, 2005) .
High TNS4 expression associated with tumour size, grade, metastasis, upregulation of EGFR and HER, and shorter cancer-specific and metastasis-free survival (Katz et al., 2007) .
Colorectal cancer
Induces the EMT, promotes cell invasion, migration (Albasri et al., 2009 (Albasri et al., , 2011a Liao et al., 2009b; Asiri et al., 2019) and cancer stemness (Liao et al., 2009b) .
Overexpressed in early and late stage (Liao et al., 2009b) . High TNS4 expression associated with a poorer survival rate, metastasis, advanced Duke's stage (Albasri et al., 2011a) .
HCC
Induces proliferation and migration (Chan et al., 2015) .
Upregulated in 43% of HCC patient samples (Chan et al., 2015) . Association between TNS4 expression and patient outcomes was not reported (Chan et al., 2015) .
Lung cancer
Induces cell proliferation (Muharram et al., 2014b) , EMT, invasion and migration (Bennett et al., 2015; Lu et al., 2018) .
Significantly upregulated in stage II, III and IV compared to adjacent normal tissue (Sasaki et al., 2003a) . Upregulated in adenocarcinoma compared to normal lung (Misono et al., 2019) . High TNS4 expression associated with poorer disease-free and overall survival (Misono et al., 2019) . Upregulated in tumour tissues compared to adjacent normal mucosa. High TNS4 expression associated with poorer 5-year overall survival (Sawazaki et al., 2017) .
Gastric cancer
Cervical cancer
Nuclear TNS4 induces cell proliferation (Hong et al., 2019a) . No data reported yet.
Esophagogastric cancer
Upregulated in 34% of 104 primary tumour samples. TNS4 expression is associated with lymphatic invasion, lymph node metastasis, and poorer overall and disease-free survival (Aratani et al., 2017a) .
Thymoma
No data reported. TNS4 mRNA expression was significantly higher in stage IV when compared to stage I (Sasaki et al., 2003c) .
Pancreatic cancer
Induce cell migration (Al-Ghamdi et al., 2011a) . No data reported. it has an SH2 domain and it has regions with homology to auxilin (a cyclin G associated kinase) 229 and to the PTEN tumour suppressor gene (Chen et al., 2002) . Additionally, TNS1 has a C2 230 tensin-like domain, which together with SH2 and PTB domains, is responsible for binding to 231 DLC1 and enhancing Rho-A activity (Shih et al., 2015) . In human primary fibroblasts, TNS1 is breast cancer xenografts in mice, TNS1 appears to have a tumour suppressor function albeit 272 through an interesting mechanism. TNS1 was found to harbour two 3'UTR binding sites for the 273 miRNA miR-548j, which functions as a metastasis-promoting miRNA. Binding of miR-548j to 274 these sites appears to regulate promote breast cancer cell invasion and metastasis by down- Therefore, TNS3 is suggested to act as a platform for the disassembly of focal adhesion 
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This suggests a role for TNS3 in the initial steps of metastasis when loss of adhesion and the 345 EMT program starts. However, in renal cell carcinoma, high methylation levels at CpG islands 346 were associated with low TNS3 expression levels, but this could be reversed to high TNS3 347 expression by demethylation of cultured kidney cells, which suggests an epigenetic mechanism 348 for the regulation of TNS3 promoter and its possible role as a tumour suppressor gene in renal 349 cancer (Carter et al., 2013) .
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In glioblastoma, the RNA-binding protein musashi-1 (MSI-1) was found to bind to the 3'UTR of also overexpressed in all CRC samples tested regardless of the stage, suggesting TNS4 may also play a role in tumour initiation and progression (Liao et al., 2009a; Albasri et al., 2011a) . 396 Interestingly, TNS4 physically interacts with Beta-catenin in CRC cell lines. (Liao et al., 2009b) . 397 We have identified an N-terminal region comprising 100 a.a. that, when deleted, abolishes the 398 co-immunoprecipitation with Beta-catenin. However, we have not detected any biological 399 function resulting of that interaction in HCT116. To determine if this interaction plays a role in 400 tumour initiation, we would have to test it in normal colorectal epithelial cells (Alfahed, 2019 in 401 preparation). A simulation of the 3D protein structure of TNS4 and its interaction domains with 402 Beta-catenin shows a long tail interacting with a grove in the armadillo structure of Beta-catenin 403 (Figure 7) . 
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The involvement of TNS4 in Beta-catenin signalling is apparent as TNS4 seems to regulate during yessotoxin-induced apoptosis (Korsnes et al., 2007) , suggesting this is a common 453 mechanism across the tensin family.
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In keeping with the other tensins, the role of TNS4 in cancer appears to be organ-dependent 455 ( Sasaki et al., 2003b; Sakashita et al., 2008; Albasri et al., 2009 Albasri et al., , 2011a Al-Ghamdi et al., 2011b; 467 Sjoestroem et al., 2013a; Chen et al., 2014; Aratani et al., 2017b; Sawazaki et al., 2017) .
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In CRC cell lines, TNS4 has been shown to induce EMT by repressing E-cadherin and to 469 significantly increase migration and invasion (Albasri et al., 2009) . TNS4 also appears to 
